Literature DB >> 17456467

A dominant negative form of the transcription factor c-Jun affects genes that have opposing effects on lipid homeostasis in mice.

Konstantinos Drosatos1, Despina Sanoudou, Kyriakos E Kypreos, Dimitris Kardassis, Vassilis I Zannis.   

Abstract

c-Jun is a transcription factor activated by phosphorylation by the stress-activated protein kinase/c-Jun N-terminal kinase pathway in response to extracellular signals and cytokines. We show that adenovirus-mediated gene transfer of the dominant negative form of c-Jun (dn-c-Jun) in C57BL/6 mice increased greatly apoE hepatic mRNA and plasma levels, increased plasma cholesterol, triglyceride, and very low density lipoprotein levels, and resulted in the accumulation of discoidal high density lipoprotein particles. A similar but more severe phenotype was generated by overexpression of the mouse apoE in C57BL/6 mice, suggesting that dyslipidemia induced by dn-c-Jun was the result of apoE overexpression. Unexpectedly, infection of apoE(-/-) mice with adenovirus expressing dn-c-Jun reduced plasma cholesterol by 70%, suggesting that dn-c-Jun affected other genes that control plasma cholesterol levels. To identify these genes, we performed whole genome expression analysis (34,000 genes) of isolated livers from two groups of five apoE(-/-) mice, infected with adenoviruses expressing either the dn-c-Jun or the green fluorescence protein. Bioinformatic analysis and Northern blotting validation revealed that dn-c-Jun increased 40-fold the apoE mRNA and reduced by 70% the Scd-1 (stearoyl-CoA-desaturase 1) mRNA. The involvement of Scd-1 in lowering plasma cholesterol was confirmed by restoration of high cholesterol levels of apoE(-/-) mice following coinfection with adenoviruses expressing dn-c-Jun and Scd-1. In conclusion, dn-c-Jun appears to trigger two opposing events in mice that affect plasma cholesterol and triglyceride levels as follows: one results in apoE overexpression and triggers dyslipidemia and the other results in inhibition of Scd-1 and offsets dyslipidemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456467      PMCID: PMC2745720          DOI: 10.1074/jbc.M700986200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Both Jun and Fos contribute to transcription activation by the heterodimer.

Authors:  S Hirai; B Bourachot; M Yaniv
Journal:  Oncogene       Date:  1990-01       Impact factor: 9.867

Review 2.  Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.

Authors:  D Bohmann; T J Bos; A Admon; T Nishimura; P K Vogt; R Tjian
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

3.  Differentiation-induced gene expression in 3T3-L1 preadipocytes. Characterization of a differentially expressed gene encoding stearoyl-CoA desaturase.

Authors:  J M Ntambi; S A Buhrow; K H Kaestner; R J Christy; E Sibley; T J Kelly; M D Lane
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

4.  Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats.

Authors:  T Chajek-Shaul; G Friedman; O Stein; E Shiloni; J Etienne; Y Stein
Journal:  Biochim Biophys Acta       Date:  1989-02-20

5.  Differentiation-induced gene expression in 3T3-L1 preadipocytes. A second differentially expressed gene encoding stearoyl-CoA desaturase.

Authors:  K H Kaestner; J M Ntambi; T J Kelly; M D Lane
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

6.  The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.

Authors:  W H Landschulz; P F Johnson; S L McKnight
Journal:  Science       Date:  1988-06-24       Impact factor: 47.728

7.  Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

Authors:  P Angel; E A Allegretto; S T Okino; K Hattori; W J Boyle; T Hunter; M Karin
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

8.  The carboxy terminus of the viral Jun oncoprotein is required for complex formation with the cellular Fos protein.

Authors:  T J Bos; F J Rauscher; T Curran; P K Vogt
Journal:  Oncogene       Date:  1989-02       Impact factor: 9.867

9.  v-jun encodes a nuclear protein with enhancer binding properties of AP-1.

Authors:  T J Bos; D Bohmann; H Tsuchie; R Tjian; P K Vogt
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

10.  The JUN oncoprotein, a vertebrate transcription factor, activates transcription in yeast.

Authors:  K Struhl
Journal:  Nature       Date:  1988-04-14       Impact factor: 49.962

View more
  12 in total

1.  Sequestration of fatty acids in triglycerides prevents endoplasmic reticulum stress in an in vitro model of cardiomyocyte lipotoxicity.

Authors:  Madeleen Bosma; Dianne H Dapito; Zoi Drosatos-Tampakaki; Ni Huiping-Son; Li-Shin Huang; Sander Kersten; Konstantinos Drosatos; Ira J Goldberg
Journal:  Biochim Biophys Acta       Date:  2014-12

2.  Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4.

Authors:  Alexander M Vezeridis; Konstantinos Drosatos; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

3.  Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology.

Authors:  Itsaso Garcia-Arcos; Yaeko Hiyama; Konstantinos Drosatos; Kalyani G Bharadwaj; Yunying Hu; Ni Huiping Son; Sheila M O'Byrne; Chuchun L Chang; Richard J Deckelbaum; Manabu Takahashi; Marit Westerterp; Joseph C Obunike; Hongfeng Jiang; Hiroaki Yagyu; William S Blaner; Ira J Goldberg
Journal:  J Biol Chem       Date:  2013-03-31       Impact factor: 5.157

4.  Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction.

Authors:  Konstantinos Drosatos; Zoi Drosatos-Tampakaki; Raffay Khan; Shunichi Homma; P Christian Schulze; Vassilis I Zannis; Ira J Goldberg
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

5.  Molecular Mechanisms Underlying the Regulation of the MFG-E8 Gene Promoter Activity in Physiological and Inflammatory Conditions.

Authors:  Xiao Wang; Heng-Fu Bu; Shirley X L Liu; Isabelle G De Plaen; Xiao-Di Tan
Journal:  J Cell Biochem       Date:  2015-09       Impact factor: 4.429

6.  MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism.

Authors:  Dimitrios Iliopoulos; Konstantinos Drosatos; Yaeko Hiyama; Ira J Goldberg; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2010-02-02       Impact factor: 5.922

7.  apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Alexander Vezeridis; Ioannis Dafnis; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

8.  Inhibition of c-Jun N-terminal kinase increases apoE expression in vitro and in vivo.

Authors:  Ana Pocivavsek; G William Rebeck
Journal:  Biochem Biophys Res Commun       Date:  2009-07-15       Impact factor: 3.575

9.  Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis.

Authors:  Chi Chen; Yatrik M Shah; Keiichirou Morimura; Kristopher W Krausz; Makoto Miyazaki; Terrilyn A Richardson; Edward T Morgan; James M Ntambi; Jeffrey R Idle; Frank J Gonzalez
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

10.  Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it.

Authors:  Zoi Drosatos-Tampakaki; Konstantinos Drosatos; Yasemin Siegelin; Shan Gong; Salmiyeh Khan; Thomas Van Dyke; Ira J Goldberg; P Christian Schulze; Ulrike Schulze-Späte
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.